Dermatology Practices in the US: Market Size, Businesses & Forecast 2026

The Dermatology Practices industry in the US comprises independent physicians and clinical groups dedicated to diagnosing and treating skin, hair, and nail disorders, as well as providing cosmetic procedures. Driven by an aging population and increasing skin cancer awareness, the sector maintains steady utilization, though regional resource distributions vary. According to the Health Resources and Services Administration (HRSA), the national workforce supply stood at 11,555 full-time equivalent (FTE) dermatologists against a demand of 12,679 FTEs in 2024, representing a structural deficit that is projected to resolve over the next decade.

Industry snapshot

Key public data points

Historical & forecast

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.

What does the Dermatology Practices in the US industry cover?

This industry consists of licensed medical practitioners holding M.D. or D.O. degrees who operate independent or group medical offices specialized in dermatology. Operators offer services ranging from medical diagnoses of skin malignancies and chronic dermatoses to surgical interventions and aesthetic treatments.

• •Primary services focus on medical, surgical, and cosmetic dermatology for outpatient populations.
• •Establishments are officially categorized under outpatient healthcare delivery networks.
• •Operations exclude specialized inpatient dermatological wards within acute care hospital systems.

Who operates in the industry and how is it structured?

The US dermatology market is characterized by a high volume of local independent practices operating alongside rapidly expanding private equity-backed management platforms. Administrative operations are frequently streamlined via Dermatology Practice Management (DPM) organizations to optimize commercial insurance and Medicare billing systems.

• •Practices utilize Electronic Health Record (EHR) systems specialized for dermatological charting and photography.
• •Clinical structures generally combine board-certified dermatologists, physician assistants, and nurse practitioners.
• •Operations heavily rely on third-party commercial payers and the Centers for Medicare & Medicaid Services (CMS) for reimbursement.

What drives demand in the industry?

The primary drivers of industry demand are shifting demographic profiles and rising public awareness regarding melanoma and non-melanoma skin cancers. Routine screening recommendations by public health agencies continue to fuel steady patient volumes across all adult age groups.

• •An aging US demographic significantly escalates the clinical incidence of actinic keratosis and carcinomas.
• •Expanded access to commercial health insurance mandates stable baseline utilization rates for medical dermatology.
• •Discretionary consumer spending directly influences out-of-pocket demand for elective aesthetic skin treatments.

Who are the notable companies in the industry?

The competitive landscape features intense regional fragmentation, though corporate consolidation has accelerated via corporate aggregators and multi-state clinical networks. Because most prominent consolidation platforms operate as privately-held or private-equity-backed entities, market participants compete closely on localized consumer access and insurer network inclusions.

• •Forefront Dermatology operates as one of the largest multi-state clinical footprints in the United States.
• •Advanced Dermatology and Cosmetic Surgery (ADCS) maintains extensive clinical facilities providing standardized medical and aesthetic skin care.
• •Schweiger Dermatology Group represents a prominent regional consolidator focused heavily throughout the Northeast corridor.
• •QualDerm Partners collaborates with physician-led practices to provide back-office management and corporate scale across multiple regions.

What are the recent trends and outlook?

The industry is experiencing a widespread shift toward consolidated corporate administrative structures to offset rising operational overhead and compliance complexities. Government projections indicate that while a localized workforce deficit existed recently, clinical supply pipelines are expected to equilibrate over the long term.

• •HRSA data from 2024 identified a nationwide supply of 11,555 FTE dermatologists compared to an estimated demand of 12,679 FTEs.
• •Widespread adoption of teledermatology protocols continues to expand triage capabilities and rural clinical reach.
• •Mid-level practitioner utilization has increased to optimize physician schedules for complex surgical procedures.

How is the industry regulated?

Dermatology practices must adhere to stringent federal and state medical regulations governing patient privacy, clinical quality standards, and billing practices. Providers are subject to continuous oversight from multiple agencies regarding statutory reimbursement models and medical licensing requirements.

• •Practices maintain compliance with the Merit-based Incentive Payment System (MIPS) administered by CMS.
• •Patient data handling is strictly dictated by the Health Insurance Portability and Accountability Act (HIPAA).
• •Clinical laboratories operating within practices for pathology processing must secure Clinical Laboratory Improvement Amendments (CLIA) certifications.

Government, statistical and trade sources used for this Claight analysis.

• HRSA Bureau of Health Workforce 2024 Projections ·
• Centers for Medicare & Medicaid Services (CMS) Regulations ·
• US Census Bureau NAICS Definitions